EUVIMEDEUVIMED entdecken
Crossref

Interleukin-33/ST2 axis involvement in atrial remodeling and arrhythmogenesis

Tzu-Yu Cheng, Yao-Chang Chen, Shao-Jung Li, Fong-Jhih Lin, Yen-Yu Lu, Ting-I Lee, Ting-Wei Lee, Satoshi Higa, Yu-Hsun Kao, Yi-Jen Chen

Translational Research · 2024

DOI: 10.1016/j.trsl.2024.01.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2024. Verfasst von Tzu-Yu Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; Di…. Hauptthemen laut MEDLINE: Atrial Remodeling, Interleukin-33, Myocytes, Cardiac. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL)-33, a cytokine involved in immune responses, can activate its receptor, suppression of tumorigenicity 2 (ST2), is elevated during atrial fibrillation (AF). However, the role of IL-33/ST2 signaling in atrial arrhythmia is unclear. This study explored the pathological effects of the IL-33/ST2 axis on atrial remodeling and arrhythmogenesis. Patch clamping, confocal microscopy, and Western blotting were used to analyze the electrical characteristics of and protein activity in atrial myocytes (HL-1) treated with recombinant IL-33 protein and/or ST2-neutralizing antibodies for 48 hrs. Telemetric electrocardiographic recordings, Masson's trichrome staining, and immunohistochemistry staining of the atrium were performed in mice receiving tail vein injections with nonspecific immunoglobulin (control), IL-33, and IL-33 combined with anti-ST2 antibody for 2 weeks. IL-33-treated HL-1 cells had a reduced action potential duration, lower L-type Ca2+ current, greater sarcoplasmic reticulum (SR) Ca2+ content, increased Na+/Ca2+ exchanger (NCX) current, elevation of K+ currents, and increased intracellular calcium transient. IL-33-treated HL-1 myocytes had greater activation of the calcium-calmodulin-dependent protein kinase II (CaMKII)/ryanodine receptor 2 (RyR2) axis and nuclear factor kappa B (NF-κB) / NLR family pyrin domain containing 3 (NLRP3) signaling than did control cells. IL-33 treated cells also had greater expression of Nav1.5, Kv1.5, NCX, and NLRP3 than did control cells. Pretreatment with neutralizing anti-ST2 antibody attenuated IL-33-mediated activation of CaMKII/RyR2 and NF-κB/NLRP3 signaling. IL-33-injected mice had more atrial ectopic beats and increased AF episodes, greater atrial fibrosis, and elevation of NF-κB/NLRP3 signaling than did controls or mice treated with IL-33 combined with anti-ST2 antibody. Thus, IL-33 recombinant protein treatment promotes atrial remodeling through ST2 signaling. Blocking the IL-33/ST2 axis might be an innovative therapeutic approach for patients with atrial arrhythmia and elevated serum IL-33.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial RemodelingInterleukin-33Myocytes, CardiacAnimalsMaleMiceAction PotentialsArrhythmias, CardiacAtrial FibrillationCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell LineHeart AtriaInterleukin-1 Receptor-Like 1 ProteinMice, Inbred C57BLNLR Family, Pyrin Domain-Containing 3 ProteinSignal Transduction

Stichwörter der Autor:innen

Atrial fibrillation (AF)Calcium–calmodulin-dependent protein kinase II (CaMKII)Interleukin-33 (IL-33)Ryanodine receptor 2 (RyR2)Suppression of tumorigenicity 2 (ST2)

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase Type 2Il1rl1 protein, mouseIl33 protein, mouseInterleukin-1 Receptor-Like 1 ProteinInterleukin-33NLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; Division of Cardiovascular Surgery, Department of Surgery, Wan Fang Hosp…
  • Department of Biomedical Engineering, National Defense Medical Center, Taipei 11490, Taiwan.
  • Division of Cardiovascular Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan; Division of Cardiovascular Surgery, Department of Surgery, School of Medicine, College of Me…
  • Division of Cardiology, Department of Internal Medicine, Sijhih Cathay General Hospital, New Taipei City 22174, Taiwan; School of Medicine, Fu-Jen Catholic University, New Taipei City 24257, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; Division of Endocrinology and Metabolism, Department o…
  • Cardiac Electrophysiology and Pacing Laboratory, Division of Cardiovascular Medicine, Makiminato Central Hospital, 1199 Makiminato, Urasoe City, Okinawa 901-2131, Japan.

Zitieren

APA

Cheng, T. Y., Chen, Y. C., Li, S. J., Lin, F. J., Lu, Y. Y., Lee, T. I., Lee, T. W., Higa, S., Kao, Y. H., & Chen, Y. J. (2024). Interleukin-33/ST2 axis involvement in atrial remodeling and arrhythmogenesis. Translational Research. https://doi.org/10.1016/j.trsl.2024.01.006

Vancouver

Cheng TY, Chen YC, Li SJ, Lin FJ, Lu YY, Lee TI, et al. Interleukin-33/ST2 axis involvement in atrial remodeling and arrhythmogenesis. Translational Research. 2024. doi:10.1016/j.trsl.2024.01.006

BibTeX
@article{Cheng2024,
  author = {Cheng, Tzu-Yu and Chen, Yao-Chang and Li, Shao-Jung and Lin, Fong-Jhih and Lu, Yen-Yu and Lee, Ting-I and Lee, Ting-Wei and Higa, Satoshi and Kao, Yu-Hsun and Chen, Yi-Jen},
  title = {Interleukin-33/ST2 axis involvement in atrial remodeling and arrhythmogenesis},
  journal = {Translational Research},
  year = {2024},
  doi = {10.1016/j.trsl.2024.01.006}
}
Kostenlos starten →